Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Aegis Transit System

K-Number: K170757 · 2017-07-14

Decision Date2017-07-14
Product CodeEWY
Advisory CommitteeEN
DecisionSubstantially Equivalent

Device Summary

Aegis Transit System is a medical device manufactured by Boston-Biomedical Associates. It received FDA 510(k) clearance on 2017-07-14 under approval number K170757. The device is classified under product code EWY. It was reviewed by the EN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Aegis Transit System?

Aegis Transit System is a medical device that received FDA 510(k) clearance on 2017-07-14. It is manufactured by Boston-Biomedical Associates. The 510(k) number is K170757.

When was Aegis Transit System approved by the FDA?

Aegis Transit System received FDA 510(k) clearance on 2017-07-14, under approval number K170757.

What company makes Aegis Transit System?

Aegis Transit System is manufactured by Boston-Biomedical Associates.

What is the FDA product code for Aegis Transit System?

The FDA product code for Aegis Transit System is EWY.

Related Clinical Trials

Related Devices (Code: EWY)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.